BlackRock
NYMX

BlackRock’s Nymox Pharmaceutical Corp NYMX Stock Holding History

BlackRock’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-38,689
Closed -$7.35K – 5633
2023
Q2 		$7.35K Sell
38,689
-96,923
-71% -$38.2K ﹤0.01% 5280
2023
Q1 		$46.1K Buy
135,612
+3,918
+3% +$1.59K ﹤0.01% 5133
2022
Q4 		$42.6K Buy
131,694
+2,612
+2% +$946 ﹤0.01% 5264
2022
Q3 		$53K Sell
129,082
-3,265
-2% -$1.3K ﹤0.01% 5342
2022
Q2 		$58K Sell
132,347
-3,138
-2% -$2.89K ﹤0.01% 5382
2022
Q1 		$171K Sell
135,485
-175
-0.1% -$270 ﹤0.01% 5144
2021
Q4 		$176K Sell
135,660
-2,008
-1% -$3.2K ﹤0.01% 5133
2021
Q3 		$283K Sell
137,668
-21,997
-14% -$39K ﹤0.01% 4899
2021
Q2 		$252K Sell
159,665
-1,768,785
-92% -$3.28M ﹤0.01% 4849
2021
Q1 		$4.28M Buy
1,928,450
+63,399
+3% +$167K ﹤0.01% 4009
2020
Q4 		$4.63M Sell
1,865,051
-3,557
-0.2% -$7.86K ﹤0.01% 3747
2020
Q3 		$4.6M Buy
1,868,608
+4,269
+0.2% +$12.4K ﹤0.01% 3610
2020
Q2 		$6.62M Buy
1,864,339
+1,746,923
+1,488% +$5.53M ﹤0.01% 3413
2020
Q1 		$275K Sell
117,416
-8,134
-6% -$22.8K ﹤0.01% 4170
2019
Q4 		$276K Sell
125,550
-5,221
-4% -$10.3K ﹤0.01% 4275
2019
Q3 		$239K Sell
130,771
-1,798
-1% -$3.14K ﹤0.01% 4304
2019
Q2 		$191K Sell
132,569
-1,509,094
-92% -$2.64M ﹤0.01% 4371
2019
Q1 		$3.23M Buy
1,641,663
+7,336
+0.4% +$15.6K ﹤0.01% 3557
2018
Q4 		$2.14M Sell
1,634,327
-215
-0% -$394 ﹤0.01% 3640
2018
Q3 		$4.02M Buy
1,634,542
+16,083
+1% +$47.5K ﹤0.01% 3562
2018
Q2 		$5.44M Buy
1,618,459
+299,752
+23% +$1.15M ﹤0.01% 3481
2018
Q1 		$5.58M Buy
1,318,707
+35,035
+3% +$121K ﹤0.01% 3381
2017
Q4 		$4.24M Buy
1,283,672
+23,444
+2% +$85.5K ﹤0.01% 3497
2017
Q3 		$4.81M Buy
1,260,228
+9,085
+0.7% +$34.4K ﹤0.01% 3474
2017
Q2 		$5.5M Buy
1,251,143
+1,167,968
+1,404% +$4.8M ﹤0.01% 3452
2017
Q1 		$302K Buy
+83,175
New +$274K ﹤0.01% 4109

Other funds holding NYMX

DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
FCFC
First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return
CAM
Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return
ODIJL
One Day In July LLC Burlington, Vermont $1.25B AUM 12.08% 1-Year Est. Return

BlackRock's NYMX Position: Q3 2023 in Review

BlackRock sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2023, closing a stake of 38,689 shares — an estimated $7.35K sold.

BlackRock first reported a position in NYMX in Q1 2017 and held it in 26 quarters. The position peaked at $6.62M in Q2 2020. 5 funds tracked by Wall St. Rank hold NYMX as of Q3 2023.

  • BlackRock reported no remaining Nymox Pharmaceutical Corp position as of Q3 2023 after selling out during the quarter.
  • BlackRock sold 38,689 Nymox Pharmaceutical Corp shares in Q3 2023, an estimated $7.35K.
  • BlackRock first reported a position in Nymox Pharmaceutical Corp in Q1 2017 and held it in 26 quarters.
  • BlackRock's Nymox Pharmaceutical Corp position peaked at $6.62M in Q2 2020.
  • 5 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2023.

Based on BlackRock's 13F filing for Q3 2023, filed 13 Nov 2023.